MedImmune Has A Higher Loss In Third Quarter
70317
MedImmune Inc. reported a third-quarter loss yesterday, despite $61 million in sales of its lead product, Synagis, a 25 percent increase over the same period a year ago.
470056
MCI Inc. yesterday reported a loss of $3.4 billion during its third quarter, reflecting its recent decision to write down the value of its telecommunications network.
120706
Merck & Co  on Monday said its third-quarter profit rose sharply, helped by sales of its vaccines and cholesterol drugs, and raised its 2007 profit forecast in view of strong current trends.
689843
3Com Corp. (COMS.O: Quote, Profile, Research) on Thursday posted a wider-than-expected second-quarter loss, amid stiff competition from Cisco Systems Inc.
654103
Bristol-Myers Squibb said yesterday that its third-quarter profit more than doubled on a resurgence in sales of the blood thinner Plavix, while the biotechnology company ImClone Systems said it swung to a third-quarter loss on higher operating costs.
738503
YESTERDAY Close $54.64 Change +$1.53 52-WEEK High $55.14 Low $42.29 Merck &amp; Co., the third-largest US drug maker, reported a 63 percent increase in earnings and raised its forecast for the year after a vaccine for cervical cancer and a new pill for diabetes drove sales higher.
4939
Citing its acquisition of MedImmune and falling demand for its ulcer treatment,  the drugmaker said earnings fell to $1.27 billion in the fourth quarter.
770376
OSI Pharmaceuticals Inc. on Monday posted a wider loss for the year ended Sept. 30, hurt by greater research and development costs and one-time charges during the period.
292602
Drugmaker Mylan Laboratories Inc.  posted a quarterly loss on Thursday on charges related to an acquisition, but reported adjusted profit that beat its previous forecast helped by sales of generic drugs for pain and bladder control.
686064
Dutch retail giant Ahold has reported a third-quarter net loss, as its results were impacted by exceptional costs and asset impairment charges.
254390
Losses ballooned to $207.3 million for the third quarter, driven by lower extended warranty sales and restructuring costs.
634339
The move comes just months after Jon Symonds completed the $15.2 billion purchase of MedImmune, which some investors considered too expensive.
42056
Bond insurer Ambac Financial Group Inc   on Tuesday reported a quarterly loss of $3.3 billion  after recording massive credit derivative write-downs and  setting aside more money for credit losses.
617164
The maker of generics releases its third-quarter results with a little time to spare.
294668
A.M.D. reported a net loss of $396 million, larger than Wall Street expected, but sales were up 23 percent on strong personal-computer demand.
674404
Telecommunications firm MCI Inc. on Thursday posted a hefty third-quarter loss, saddled by costs from writing down the value of its network as the reorganized telecom faces intensifying industry competition.
196100
Third-quarter profit fell 1 percent, as stronger sales of almost all of the companyâs key drugs could not offset  higher production costs and taxes and a restructuring charge.